Michael Martin Breen - 15 Jul 2022 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Exec. Chair. and Interim CEO, Director
Signature
/s/ Michael Martin Breen
Issuer symbol
GTBP
Transactions as of
15 Jul 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 21:48:20 UTC
Previous filing
12 Nov 2021
Next filing
01 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTBP Common Stock Award $0 +278,058 +85% $0.000000 606,218 15 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50,000 $0.000000 50,000 15 Jul 2022 Common Stock 50,000 $2.48 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.